NWBO

Northwest Biotherapeutics, Inc. News Headlines

$7.37
*  
0.09
1.21%
Get NWBO Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading NWBO now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Mark Your Calendar For TCON, XLRN, Xenon Lights Up, MACK Gets Going
2/19/2015 11:39:00 PM - RTT News


Northwest Has A Differentiated Technology Platform In The Emerging Immuno-Oncology Landscape
2/6/2015 12:08:00 PM - Seeking Alpha


Is Northwest Biotherapeutics A Bargain? Yes!
1/5/2015 12:17:00 AM - Seeking Alpha


Northwest Biotherapeutics: An Analysis Of What We Know About DCVax Direct
12/1/2014 6:23:00 AM - Seeking Alpha


Northwest Biotherapeutics' DCVax-L: A Reimbursement Perspective
11/23/2014 4:41:00 AM - Seeking Alpha


Update: Northwest Bio Benefits From Two Financings, Woodford Makes Encouraging Investment
11/21/2014 8:16:00 AM - Seeking Alpha


Northwest Biotherapeutics: Capital Raise Of $35 Million Could Be A Positive Catalyst For The Stock
11/20/2014 11:21:00 AM - Seeking Alpha


Celldex Therapeutics To Enter Talks With FDA
11/18/2014 10:26:00 AM - Seeking Alpha


The Time Is Now For Northwest Biotherapeutics
10/29/2014 3:16:00 PM - Seeking Alpha


Northwest Bio's Latest Financing Abuses Its Shareholders: Is The Charade Over?
10/8/2014 2:26:00 PM - Seeking Alpha


Update: Northwest Biotherapeutics Announces $11 Million Financing, Harms Shareholders Again
10/8/2014 9:04:00 AM - Seeking Alpha


Northwest Biotherapeutics Misrepresents Clinical Trial Data
10/1/2014 11:14:00 AM - Seeking Alpha


The Case Of Northwest Biotherapeutics
9/29/2014 1:35:00 PM - Seeking Alpha


Northwest Biotherapeutics Valuation = $0
9/26/2014 6:14:00 PM - Seeking Alpha


Update: Northwest Biotherapeutics Stock In Turmoil, But Not For Long
9/23/2014 1:49:00 PM - Seeking Alpha


Northwest Biotherapeutics: U.K. May Grant Early Patient Access For DCVax-L Prior To Formal Approval
9/18/2014 4:02:00 AM - Seeking Alpha


Northwest Bio: The Data Monitoring Committee Addresses The Status Of The DCVax-L Trial
8/13/2014 6:17:00 PM - Seeking Alpha


Northwest Bio - You Can See This Data, But Not That Data
8/13/2014 9:35:00 AM - Seeking Alpha


Cel-Sci Is A Leader In The I-O Class Of Cancer Therapies
8/12/2014 10:43:00 AM - Seeking Alpha


Northwest Bio And The Curious Relationship With Cognate BioServices
7/17/2014 6:55:00 PM - Seeking Alpha


Northwest Biotherapeutics: Responding To Richard Pearson's Article Alleging A Promotion Scheme
7/17/2014 8:25:00 AM - Seeking Alpha


Why Immunotherapies Have Made DelMar's Lead Drug A Necessity In Brain Cancer
7/15/2014 2:40:00 PM - Seeking Alpha


Behind The Promotion Of Northwest Bio
7/7/2014 10:46:00 AM - Seeking Alpha


Behind The Promotion Of Northwest Bio
7/7/2014 9:35:00 AM - Seeking Alpha


Placing Northwest Biotherapeutics In The Figure-4 Deadfall Trap
6/26/2014 11:22:00 AM - Seeking Alpha